Abstract:Commercial coenzyme Q10 (CoQ10, ubiquinone) formulations are often of poor intestinal absorption. The relative bioavailability of CoQ10 has been shown in National Institutes of Health-funded clinical trials to be increased by its delivery system. We investigated the bioavailability of a new CoQ10 formulation based on a new and patented technology, VESIsorb, with 3 other commercially available CoQ10 products, an oil-based formulation and 2 solubilizates. This new CoQ10 formulation (commercially branded CoQsource) is a lipid-based formulation that naturally self-assembles on contact with an aqueous phase into an association colloid delivery system (hereafter "colloidal-Q10"). Twenty healthy male and female subjects participated in a double-blind, comparative (parallel design), controlled, single-dose (120 mg) bioavailability study. Plasma concentration of CoQ10 was determined at baseline and at various intervals after administration over a 24-hour period. To compare bioavailability, maximum concentration (Cmax) and area under curve from 0 to 10 hours (AUC(0-10h)) were assessed. The kinetic profiles of all CoQ10 preparations revealed a 1-peak plasma concentration-time course. Highest Cmax values were seen after colloidal-Q10 administration. Colloidal-Q10 not only had the highest plasma concentration levels after 1 hour, but it continued to increase before reaching Cmax at about 4 hours. The plasma concentration of colloidal-Q10 remained well above the levels of the 3 other products throughout the 24-hour period. The relative bioavailability calculated using the AUC(0-10h) values was also the highest for colloidal-Q10; the AUC(0-10h) values were 30.6, 6.1, 4.9, and 10.7 microg/mL*h for colloidal-Q10, solubilizate 1, the oil-based formulation, and solubilizate 2, respectively. Differences in Cmax and AUC between colloidal-Q10 and the 3 other formulations were statistically significant. In summary, the data presented suggests that colloidal-Q10 improves the enteral absorption and the bioavailability of CoQ10 in humans.

Solubility Measurements and Prediction of Coenzyme Q10 Solubility in Different Solvent Systems

Experimental Measurement and Modeling of the Solubility of Biotin in Six Pure Solvents at Temperatures from 298.15 K to 333.85 K

Solubility Measurement and Correlation of (+)-Biotin Intermediate Lactone in Different Organic Solvents from 287.15 to 323.75 K

Solubilities Of Cholesterol And Desmosterol In Binary Solvent Mixtures Of N-Hexane Plus Ethanol

Solubility Measurement of Cholesterol in Several Solvents from 283.2 to 323.2 K

Solubility of Desmosterol in Five Organic Solvents

Preparation of Coenzyme Q0

Solubility prediction for cholesterol and desmosterol in mixed solvents via NRTL-SAC and COSMO-RS

Measurement and Correlation of Solubilities of Apigenin and Apigenin 7-O-rhamnosylglucoside in Seven Solvents at Different Temperatures

Solubilities of Dodecylpolyoxyethylene Polyoxypropylene Ether in Supercritical Carbon Dioxide

Development and Optimization of Antisolvent Cooling Coupled Crystallization Process for Coenzyme Q10

Solubilities of cholesterol and desmosterol in binary solvent mixtures of n-hexane + ethanol

Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations

Estimating rates of population change for a neotropical parrot with ratio, mark-recapture and matrix methods

Solubility Determination of Nicotinamide and Its Application for the Cocrystallization with Benzoic Acid

Enhancing solubility and bioavailability of coenzyme Q10: formulation of solid dispersions using Soluplus® as a carrier

Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system

Solubility Determination and Correlation of 4-(Bromomethyl)-2(1H)-quinolinone in Different Pure Solvents Over the Temperature Range from 273.15 to 313.15 K

Measurement and correlation of solubility of trans-resveratrol in 11 solvents at T = (278.2, 288.2, 298.2, 308.2, and 318.2) K

PEGylated Solanesol for Oral Delivery of Coenzyme Q 10 .

Solubility measurement, modeling, and solvent effect of m-hydroxyacetophenone in ten pure and binary mixed solvents from T = (289.15–325.15) K